Morgan Stanley Neuro Bo Pharmaceuticals, Inc. Transaction History

Morgan Stanley

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.72 - $1.54 $15 - $33	-22 Reduced 22.45%	76 $0
Q4 2021 Feb 14, 2022	SELL	$1.22 - $2.5 $52 - $107	-43 Reduced 30.5%	98 $0
Q3 2021 Nov 15, 2021	BUY	$2.73 - $4.52 $384 - $637	141 New	141 $0

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.